Update: FDA does not freeze CRL trove as ‘radical transparency’ push hits speedbump

RegulatoryNegative

AI Analysis

Summary

An unnamed pharmaceutical company filed a citizen petition in April requesting FDA reforms to increase transparency in the public release of Complete Response Letters, claiming the current policy contradicts established agency practice.

Outcome Details

Citizen petition filed seeking reforms to FDA's policy on public release of Complete Response Letters (CRLs)

Importance:3/10

Sentiment:

-0.30

regulatoryFDAtransparencycitizen petitionCRL

Read the original article

Published by BioSpace on July 23, 2026 5:43 PM

Read Original